The first ten days of Donald Trump’s presidency have been just as extreme as many had feared including those of us in the scientific community, but the early reactions of scientists to fight Trump’s agenda have been encouraging. We’ve collectively been sparked to “get out of the lab” and do something about it. There are many […]
Scientists battle Trump agenda on multiple fronts Read More »
What are the latest developments in stem cells and regenerative medicine in this first week of 2017 and right before the end of the past year? Here are some of the headlines and papers that have popped up that seem notable or surprising. Be sure to also check out our stem cell & regenerative medicine
TGIF: Week’s Stem Cell Headlines, Papers, & Resources Read More »
I received a score of great nominations for the Stem Cell Person of the Year 2016 Award and have briefly described the twenty nominees below. The point of the award is to honor the top positive stem cell leader who specifically thinks outside the box and takes risks. I’ve started an on-line vote where you can vote once per day for
20 Nominees for Stem Cell Person of the Year 2016 Award Read More »
I’ll be on NPR’s @hereandnow w/Robin Young in about 40 minutes talking stem cell clinics. #Stemcell clinics thrive in US despite lack of @US_FDA regs. Is it #SnakeOil? @Pknoepfler thinks so. https://t.co/NxJ5z3IVGw @hereandnow — Karyn Miller-Medzon (@KBMM) September 1, 2016 Listen in if you have the chance and the segment will also be archived on
I’m on NPR’s Here & Now Talking Stem Cell Clinics in ~40 minutes Read More »
The FDA’s CBER branch recently issued a warning letter to Amniotic Therapies, LLC. The warning letter pertains to both AlphaGEMS-related products that are used by a number of stem cell clinics as well as problems determined at the manufacturing facility. I went to the Amniotic Therapies website, but perhaps not coincidentally it is down, which
FDA warning to Amniotic Therapies, LLC: impact on stem cell clinics? Read More »
When potentially game changing new technologies are reported such as NgAgo gene editing, both scientists and the public get excited, but especially if such new reports stem from a single paper it is wise to take a cautious approach for a while. The key question is whether the new findings will turn out to be
Nature Biotechnology looking at NgAgo paper amidst reproducibility concerns Read More »
The local stem cell clinic here in Sacramento, Nervana Stem Cell Centers, continues to advertise treatments in The Sacramento Bee and there continue to be big questions about this situation. I’ve blogged about Nervana before and you can see the archived posts here. Nervana must be spending big money on advertising because they have run many
Nervana stem cell clinic: big ads in SacBee & big questions continue Read More »
By Elliot Hosman Summary. A campaign calling for a moratorium on using CRISPR in human embryos was launched by a prominent French organization fighting for narrow understandings of life and family. A recent campaign calling for a ban on “transgenic” human embryos was launched by one of France’s most prominent organizations fighting for “science”-backed “one-man-one-woman”
Hateful politics infiltrate human genome editing debate in France Read More »
I talked last year about human genetic modification by CRISPR with George Church a year ago. Now we’ve followed up with a long chat on this topic going into much more detail and with questions on recent developments. Each question is listed numerically and then there is a back and forth on that question with George
George Church chat: CRISPR people, Zika, weapons Read More »
It’s been a busy few weeks for the CRISPR arena so I’ve made a CRISPR Update. I’ve listed below links to some commentaries and key developments. CRISPR update Fun Video interview on Read Science! with Joanne Manaster on my new book on CRISPR in humans, GMO Sapiens. CRISPR: Pursuit of profit poisons collaboration, Nature piece by Jacob Sherkow HIV
CRISPR Update: Patents, Embryos, & IPOs Read More »